EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Recent Progress of Molecular Design in Organic Type I Photosensitizers

Tao Xiong iD, Yingchao Chen, Mingle Li, Xiaoqiang Chen, Xiaojun Peng iD

Small · 2025-06 · 21 (22)

DOI: 10.1002/smll.202501911 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 26.04.2025. Verfasst von Tao Xiong und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518071, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Drug Design. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Shenzhen University 2035 Program for Excellent Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) represents a high‐efficient and non‐invasive therapeutic modality for current and future tumor treatments, drawing extensive attention in the fields of antitumor drug and clinical phototherapy. In recent years, the photosensitizer (PS) market and PDT clinical applications have expanded to address various cancers and skin diseases. However, hypoxic environment within tumors poses a substantial challenge to the therapeutic capability of reactive oxygen species‐dependent PDT. Consequently, researches have increasingly focus from the type II to type I PDT mechanism, which relies on radical production with less or no oxygen dependence. Despite significant progress in the development of type I PSs, a holistic understanding regarding the design principles for these molecules remains elusive. Specifically, electron transfer‐mediated type I PDT are extensively studied in recent years but is insufficiently addressed in existing reviews. This review systematically summarizes recent advancements in the molecular design rationales of organic type I PSs, categorizing them into three key fundamental strategies: modulating PS charge distribution, singlet oxygen forbidden via low triplet excited state, and accelerating PS radical formation via inducing electron transfer. This review aims to offer valuable insights for the future type I PS design and the advancement of anti‐hypoxia PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsDrug DesignPhotochemotherapyHumans

Stichwörter der Autor:innen

hypoxic tumormolecular designphotodynamic therapytype I photosensitizers

Substanzen

Photosensitizing Agents

Autor:innen und Institutionen

  • State Key Laboratory of Fine Chemicals, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518071, China.
  • State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials, Dalian University of Technology, Dalian, 116024, China.

ORCID-Profile: Tao Xiong, Xiaojun Peng

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Shenzhen University 2035 Program for Excellent Research
  • Research Team Cultivation Program of ShenZhen University
  • National Postdoctoral Researcher Program of China
  • China Postdoctoral Science Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Xiong, T., Chen, Y., Li, M., Chen, X., & Peng, X. (2025). Recent Progress of Molecular Design in Organic Type I Photosensitizers. Small, 21(22). https://doi.org/10.1002/smll.202501911

Vancouver

Xiong T, Chen Y, Li M, Chen X, Peng X. Recent Progress of Molecular Design in Organic Type I Photosensitizers. Small. 2025;21(22). doi:10.1002/smll.202501911

BibTeX
@article{Xiong2025,
  author = {Xiong, Tao and Chen, Yingchao and Li, Mingle and Chen, Xiaoqiang and Peng, Xiaojun},
  title = {Recent Progress of Molecular Design in Organic Type I Photosensitizers},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {22},
  doi = {10.1002/smll.202501911}
}
Kostenlos starten →